Yahoo
OTC Markets OTCQB - Delayed Quote USD

Biotricity, Inc. (BTCY)

0.0560 +0.0039 (+7.49%)
At close: November 6 at 4:00:00 PM EST

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Dr. Waqaas Al-Siddiq Ph.D.
Founder, President, CEO & Chairman 732k -- 1985
Mr. S. John Ayanoglou
Chief Financial Officer 562k -- 1966
Mr. Amjad Talpur
Senior Director of Operations -- -- --
Mr. Matt Zabel
Vice President of Sales & Strategy -- -- --
Mr. Amir Ali
Chief Development Officer -- -- --
Mr. Spencer LaDow
CISO and Executive VP of Engineering & Regulatory -- -- --
Dr. Fareeha Siddiqui
Executive Vice President of Healthcare Solutions -- -- --

Biotricity, Inc.

203 Redwood Shores Parkway
Suite 600
Redwood City, CA 94065
United States
800 590 4155 https://www.biotricity.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
46

Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

Corporate Governance

Biotricity, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 12, 2026 at 9:00 PM UTC

Biotricity, Inc. Earnings Date

Recent Events

October 7, 2026 at 12:00 AM UTC

RW: Registration Withdrawal Request

September 28, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 19, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 17, 2026 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

July 14, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

June 29, 2026 at 12:00 AM UTC

NT 10-K: Periodic Financial Reports

June 16, 2026 at 12:00 AM UTC

DEF 14C: Proxy Statements

May 29, 2026 at 12:00 AM UTC

PRE 14C: Proxy Statements

May 1, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 18, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: